This could provide a transport-independent, amino-acid-sensing ‘transceptor' mechanism, in keeping with previous suggestions for the PATs.17 Cells would become more resistant to depletion of highly metabolised amino acids by expressing more PAT4, explaining the clinical data from colorectal cancer patients. Here, SLC36A4 is linked to colorectal cancer.